
Tucaliv contains Tucatinib 150 mg, a targeted therapy used to treat HER2-positive breast cancer by blocking cancer cell growth signals.
| Manufacturer | Natco |
| Generic Name | Tucatinib |
| Strength | 150mg |
| Package size | 60 Tablets |
| Used for | HER2-positive breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
Tucatinib is a targeted therapy that selectively blocks the HER2 (human epidermal growth factor receptor 2) protein. By inhibiting HER2 signaling, it stops cancer cells from growing and dividing, helping slow tumor progression.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.